Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in EuropeSHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe. This collaboration aims to promote the accessibility of toripalimab in Europe, offering high-quality, innovative treatments to patients across up to 32 European countries.
Brunswick Corporation Earns Spot on Forbes' Inaugural List of America's Most Trusted CompaniesMETTAWA, Ill., Jan. 20, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (
NYSEBC), the world’s largest marine technology company, has been named to Forbes' inaugural 2025 list of America’s Most Trusted Companies. Among the thousands of companies that were researched for this honor, only 300 made the final list. Brunswick ranked eighth within the Engineering and Manufacturing category.
Orderly Deploys on Sonic’s EVM to Deliver Omnichain LiquiditySINGAPORE, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Web3 liquidity layer Orderly has announced that it has deployed its chain-agnostic infrastructure on EVM Layer 1 Sonic. Orderly’s integration will bring its omnichain orderbook to Sonic, enabling developers and users of the new L1 to access deep liquidity.
Rivalry Adds $TRUMP Meme Coin as Crypto Payment MethodGlobal Crypto Casino Rivalry Becomes First Betting Operator to Accept U.S. President-Elect Donald Trump’s Official Solana Meme Coin $TRUMP for Deposit
MBZUAI welcomes the world to Abu Dhabi for a leading NLP conferenceABU DHABI, United Arab Emirates, Jan. 18, 2025 (GLOBE NEWSWIRE) -- The 31st International Conference on Computational Linguistics (COLING 2025) launches in Abu Dhabi tomorrow (19 January), with local organizers Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) welcoming more than 1,500 global attendees.
Blockchain Ball: Honoring the Inauguration of the 47th President and Celebrating Blockchain’s Role in the Global Economy At The Kennedy Center, Washington DCWASHINGTON, Jan. 18, 2025 (GLOBE NEWSWIRE) -- In a historic celebration of leadership and technological innovation, Brock Pierce, DNA Holdings, and Ambassador Paolo Zampolli are proud to host the Blockchain Ball, an exclusive event honoring the inauguration of the 47th President of the United States, Donald J. Trump. This distinguished gathering will highlight blockchain’s transformative impact on the global economy while celebrating a new era of leadership.
TELUS ALERT: Bragar Eagel & Squire, P.C. is Investigating TELUS International (Cda) Inc. on Behalf of TELUS Stockholders and Encourages Investors to Contact the FirmNEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TELUS International (Cda) Inc. (“TELUS” or the “Company”) (
NYSETIXT) on behalf of TELUS stockholders. Our investigation concerns whether TELUS has violated the federal securities laws and/or engaged in other unlawful business practices.
SIMPPLE Ltd. Receives Nasdaq Notifications Regarding Minimum Stockholders’ Equity Deficiency and Annual Meeting DeficiencySingapore, Jan. 17, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (
NASDAQSPPL) (“SIMPPLE” or “the Company”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that it has received letters from the Listing Qualification staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that the Company does not meet the minimum stockholders’ equity requirement and annual meeting requirement.
INVESTIGATION ALERT (NASDAQ: WBA): DiCello Levitt LLP Is Investigating Investor Claims Against Walgreens Boots Alliance, Inc. and Encourages WBA Investors with Losses to Contact the FirmSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (
NASDAQWBA) violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors.
Uniti Group Inc. Announces Pricing of $589 Million Fiber Securitization Notes OfferingLITTLE ROCK, Ark., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that Uniti Fiber ABS Issuer LLC and Uniti Fiber TRS Issuer LLC, limited-purpose, bankruptcy remote subsidiaries of Uniti (collectively, the “Issuers”), have priced their offering of $589,000,000 aggregate principal amount of secured fiber network revenue term notes, consisting of $426,000,000 5.9% Series 2025-1, Class A-2 term notes, $65,000,000 6.4% Series 2025-1, Class B term notes and $98,000,000 9.0% Series 2025-1, Class C term notes, each with an anticipated repayment date in April 2030 (collectively, the “Notes”). Collectively, the Notes have a weighted average yield of approximately 6.5%. The Notes will be secured by certain fiber network assets and related customer contracts in the State of Florida and the Gulf Coast region of Louisiana, Mississippi and Alabama. Each of the Issuers and its direct parent entities and subsidiaries have been designated as “unrestricted subsidiaries” under Uniti’s credit agreement and the indentures governing its outstanding senior notes. The offering is expected to close on February 3, 2025.
President Biden Grants Clemency to Over 2,500 Drug War Victims in Final DaysLPP Applauds the President’s Actions Addressing Disparate Harms From the War on Drugs After Years of Advocacy.
BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class ActionSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (
NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
Robbins LLP Urges MU Stockholders with Large Losses to Contact the Firm for Information About the Micron Technology, Inc. Class ActionSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (
NASDAQMU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices.
Lifecore Biomedical Announces Special Stockholder MeetingCompany Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms
Robbins LLP Urges REGN Stockholders with Large Losses to Contact the Firm for Information About the Class Action Against Regeneron Pharmaceuticals, IncSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (
NASDAQREGN) securities between November 2, 2023 and October 30, 2024. Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQIOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on January 16, 2025 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 224,550 shares of Iovance’s common stock to forty-one new, non-executive employees.
MBDA’s Eric Morrissette Launches MBDA’s Innovation Lab to Empower Minority Business EnterprisesWASHINGTON, DC, Jan. 17, 2025 (GLOBE NEWSWIRE) -- In his final act, the outgoing Head of MBDA, Eric Morrissette, unveiled the Minority Business Development Agency’s (MBDA) Innovation Lab, a transformative series of initiatives designed to harness technology and innovation in support of minority business enterprises (MBEs).
SBA Administrator Guzman Outlines New MySBA Digital Experience Transforming How Business Owners Interact with SBANew MySBA Experience Builds on SBA’s Efforts to Transform Customers’ Experiences with the Agency via Innovative Digital Tools
Fortis Inc. to Hold Teleconference and Webcast on February 14 to Discuss 2024 Annual ResultsST. JOHN'S, Newfoundland and Labrador, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE: FTS) will release its 2024 financial results on Friday, February 14, 2025. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern). David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation's 2024 annual financial results.
Jianzhi Education Technology Group Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyBEIJING, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (
NASDAQJZ), a leading provider of digital educational content in China, today announced that the Company has received written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated January 15, 2025, indicating that for the last 30 consecutive business days, the closing bid price for the Company’s American depositary shares (the “ADSs”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rules. The Nasdaq notification letter has no current effect on the listing or trading of the Company’s ADSs on The Nasdaq Capital Market.
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, effective January 1, 2025, the company granted a non-qualified stock option to purchase 60,000 shares of its common stock to one new employee under Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQRARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 7,750 restricted stock units of the company’s common stock to eight newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of January 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (
NYSESYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding shares of common stock of Inari Medical, Inc.
NASDAQ: NARINASDAQNARI)
Wellchange Holding Company Limited Announces Closing of $10 Million Public Offering of its Ordinary SharesHong Kong, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Wellchange Holding Company Limited (
NASDAQWCT) (“Company” or the “Wellchange”), an enterprise software solution services provider headquartered in Hong Kong, today announced the closing of its public offering of 25,000,000 ordinary shares at a public offering price of $0.40 per ordinary share.
FTAI Aviation Announces Full Redemption of Outstanding 8.00% Fixed-to-Floating Rate Series B Cumulative Perpetual Redeemable Preferred SharesNEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; “FTAI Aviation” or the “Company”) announced today that it will redeem all of the Company’s outstanding 4,940,000 8.00% Fixed-to-Floating Rate Series B Cumulative Perpetual Redeemable Preferred Shares (the “Series B Shares”) at a redemption price equal to $25.00 per Series B Share in cash, plus $2,405,404.25 of accumulated and unpaid distributions thereon to, but not including, the redemption date of February 16, 2025 (the “Redemption”). The Series B Shares trade under the ticker symbol “FTAIO.”
Phillips Edison & Company Announces Tax Reporting Information for 2024 DistributionsCINCINNATI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced its tax reporting information for the 2024 distributions to holders of its common stock.
Armlogi Holding Corp. Announces Donation to Support Los Angeles Wildfire Relief EffortsCompany to Donate Over $110,000 in Essential Equipment to Support Local Emergency Response
Core Specialty Completes Acquisition of London Aviation Underwriters; Forms Aviation & Aerospace DivisionCINCINNATI, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Core Specialty Insurance Holdings, Inc. and its subsidiaries (“Core Specialty” or the “Company”) announced today that it has completed the acquisition of London Aviation Underwriters, Inc. (“LAU”) which was previously announced on January 6, 2025. The completed transaction represents Core Specialty’s 18th specialty business unit, adding to the Fronted Programs subsegment.
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)WATERTOWN, Mass., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (
NASDAQIRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the grant of an inducement equity award to a new employee, effective January 16, 2025.
Wearable Devices Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-ComplianceYokneam Illit, Israel, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, today announced that it has received a written notification (the "Notification Letter") from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market, listing Rule 5550(b)(1), due to its failure to maintain a minimum of $2,500,000 in stockholders' equity. In the Company's Report of Foreign Private Issuer on Form 6-K, dated September 23, 2024, the Company reported stockholders' equity of approximately $1,695,000 as of June 30, 2024.
Global Value Investment Corporation’s Interim CEO and President JP Geygan Appointed to Fluent, Inc.’s Board of DirectorsMILWAUKEE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Global Value Investment Corporation (GVIC), an investment firm specializing in disciplined, value-oriented investing, announces Interim CEO and President JP Geygan's appointment to the Board of Directors of Fluent, Inc. (
NASDAQFLNT), a leading commerce media solutions company.
Scorpius Holdings Cancels Planned Reverse Stock SplitDURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that the Company’s planned 1-for-20 reverse stock split (the “Reverse Stock Split”) of its common stock (the “Common Stock”) that was announced yesterday, will not be effectuated.
AGBU Cultural Center Opens Doors to Students of Sahag Mesrob Armenian Christian School After Devastating LA FireNew York, NY, USA, Jan. 17, 2025 (GLOBE NEWSWIRE) -- AGBU Cultural Center Opens Doors to Students of Sahag Mesrob Armenian Christian School After Devastating LA Fire
Ashton Thomas Private Wealth Announces Key Hires; Bolsters West Coast PresenceFirm has established new office hub in San Francisco to service West Coast market
INVESTIGATION ALERT (NASDAQ: FTAI): DiCello Levitt LLP Is Investigating Investor Claims Against FTAI Aviation Ltd. and Encourages FTAI Investors with Losses to Contact the FirmSAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether FTAI Aviation Ltd. (“FTAI” or the “Company”) (
NASDAQFTAI) violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors.
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.30 PER COMMON SHARENEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Value Line, Inc. (
NASDAQVALU) announced today that its Board of Directors declared on January 17, 2025 a quarterly cash dividend of $0.30 per common share, payable on February 10, 2025, to stockholders of record on January 27, 2025. The Company has 9,417,264 shares of common stock outstanding as of January 17, 2025.
GUTHRIE OFFERS LANDMARK SIGN-ON BONUS IN ONGOING NURSE RECRUITMENT EFORTSBinghamton, N.Y. / Sayre, Pa, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The Guthrie Clinic has announced details of a major nurse recruitment campaign for Guthrie Lourdes Hospital in Binghamton, N.Y., and Guthrie Robert Packer Hospital in Sayre, Pa.
Creative Spirit Rings NYSE Opening Bell, Championing Inclusion in the WorkforceMilestone underscores Creative Spirit’s leadership in advancing hiring neurodivergent talent at the best companies in the world
Money Management International Reports Surge in Debt Counseling in 2024, Disproportionate Increase Among Young AdultsNonprofit credit counselor sees 35% increase in demand, 11% increase in housing costs, 8% increase in unsecured debt, and 7% increase in monthly expenses among new clients
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025LAKEWOOD, Colo., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (
NASDAQMLAB) will issue a press release with financial results for the third quarter of fiscal year 2025 at approximately 8:00 A.M. Eastern time on Tuesday, February 4, 2025.
YES Communities Expands Impact Through YES We Care ProgramDenver, Colorado, Jan. 17, 2025 (GLOBE NEWSWIRE) -- YES Communities is proud to make a lasting, positive impact in the communities it serves through the YES We Care Program. Since its inception in 2018, YES We Care has provided over $1.3 million in community assistance funding to residents, team members, and charitable organizations. The program offers specialized initiatives such as We Build Community Paid Time Off, Paid Time Off Donation Program, Hug-A-Home, and Helping Hands Assistance.
Transaction in Own SharesTransaction in Own Shares
Five Star Bancorp Declares Fourth Quarter Cash DividendRANCHO CORDOVA, Calif., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.20 per share on the Company’s voting common stock. The dividend is expected to be paid on February 10, 2025, to shareholders of record as of February 3, 2025.
Faruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLTFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Applied Therapeutics To Contact Him Directly To Discuss Their Options
TX RX Systems Introduces a Bi-Directional Amplifier That Redefines Excellence in RF Communication TechnologyANGOLA, N,Y., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Just one year after compiling a team of DAS Engineering experts to spearhead TX RX System’s re-entry into in-building RF solutions, their dedicated DAS department is redefining the landscape of inbuilding DAS Solutions. TX RX Systems, founded by the visionary Daniel P. Kaegebein—the original patent holder of the Bi-Directional Amplifier—proudly announces the release of its most ambitious and advanced Bi-Directional Amplifier to date. Engineered with precision and built to tackle the most complex communication challenges, this product celebrates decades of expertise, innovation, and dedication to the RF industry.
